International Clinical Psychopharmacology
译名:国际临床精神药理学
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
3-5
2026
影响因子区间
—
平台估算
4%
2025
中国作者发文占比
—
收费
期刊简介:International Clinical Psychopharmacology provides an essential link between research and clinical practice throughout psychopharmacology. It reports on studies in human subjects, both healthy volunteers and patients, which relate the effects of drugs on psychological processes.A major objective of the journal is to publish fully refereed papers which throw light on the ways in which the study of psychotropic drugs can increase our understanding of psychopharmacology. To this end the journal publishes results of early Phase I and II studies, as well as those of controlled clinical trials of psychotropic drugs in Phase II and IV. Other topics covered include the epidemiology of psychotropic drug prescribing and drug taking, the sociology of psychotropic drugs including compliance, and research into the safety and adverse effects of these compounds.
【译文】国际临床药理学期刊在精神药理学的研究与临床实践之间架起了一座桥梁。它报道了关于人体受试者(包括健康志愿者和患者)的研究,这些研究探讨了药物对心理过程的影响。该期刊的主要目标是发表经过充分审稿的论文,这些论文有助于阐明研究精神药物的方式如何增进我们对精神药理学的理解。为此,期刊发表了早期I期和II期研究的结果,以及II期和IV期精神药物对照临床试验的结果。其他涵盖的主题包括精神药物处方的流行病学和用药社会学,包括依从性,以及这些化合物安全性和不良反应的研究。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q2 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 3-5 | 暂无 |